Age related changes in selenium and glutathione levels in different lobes of the rat prostate

Experimental Gerontology

Volumn 47, Issue 3, 2012, Pages 223-228

  Richie, John P ^a   Das, Arunangshu ^a   Calcagnotto, Ana M ^a   Aliaga, Cesar A ^a   El Bayoumy, Karam ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Cancer; Glutathione; Oxidative stress; Prostate; Rats; Selenium

Indexed keywords

GLUTATHIONE; SELENIUM;

AGE; AGED; AGING; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CARCINOGENESIS; CONTROLLED STUDY; MALE; NONHUMAN; ORGAN WEIGHT; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE; PROSTATE ANTERIOR LOBE; PROSTATE CANCER; PROSTATE DORSOLATERAL LOBE; PROSTATE VENTRAL LOBE; PROSTATE WEIGHT; RAT;

AGING; ANIMALS; BODY WEIGHT; GLUTATHIONE; MALE; ORGAN SIZE; PROSTATE; RATS; RATS, INBRED F344; SELENIUM;

ANIMALIA; RATTUS;

EID: 84857061115     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.11.015     Document Type: Article

References (67)

1. Arnaud J., Akbaraly T.N., Hininger I., Roussel A.M., Berr C. Factors associated with longitudinal plasma selenium decline in the elderly: the EVA study. J. Nutr. 2007, 18:482-487.
2. Bagchi M., Bagchi D., Patterson E.B., Tang L., Stohs S.J. Age-related changes in lipid peroxidation and antioxidant defense in Fischer 344 rats. Ann. N. Y. Acad. Sci. 1996, 793:449-452.
3. Banerjee S., Banerjee P.P., Brown T.R. Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age. Endocrinology 2000, 141:821-832.
4. Bates C.J., Thane C.W., Prentice A., Delves H.T. Selenium status and its correlates in a British national diet and nutrition survey: people aged 65 years and over. J. Trace Elem. Med. Biol. 2002, 16:1-8.
5. Bethel C.R., Chaudhary J., Anway M.D., Brown T.R. Gene expression changes are age-dependent and lobe-specific in the brown Norway rat model of prostatic hyperplasia. Prostate 2009, 69:838-850.
6. Bhusari S.S., Dobosy J.R., Fu V., Almassi N., Oberley T., Jarrard D.F. Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate. Epigenetics 2010, 5:402-409.
7. Bostwick D.G., Alexander E.E., Singh R., Shan A., Qian J., Santella R.M., Oberley L.W., Yan T., Zhong W., Jiang X., Oberley T.D. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 2000, 89:123-134.
8. Bracarda S., de Cobelli O., Greco C., Prayer-Galetti T., Valdagni R., Gatta G., de Braud F., Bartsch G. Cancer of the prostate. Crit. Rev. Oncol. Hematol. 2005, 56:379-396.
9. Brenneisen P., Steinbrenner H., Sies H. Selenium, oxidative stress, and health aspects. Mol. Aspects Med. 2005, 26:256-267.
10. Brigelius-Flohe R., Flohe L. Is there a role of glutathione peroxidases in signaling and differentiation?. Biofactors 2003, 17:93-102.
11. Celec P., Conn P.M. Benign prostatic hyperplasia. Handbook of Models for Human Aging 2006, 641-649. Academic Press, Burlington, MA. P.M. Conn (Ed.).
12. Clark L.C., Combs G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher J.L., Park H.K., Sanders B.B., Smith C.L., Taylor J.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996, 276:1957-1963.
13. Coles B., Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 1990, 25:47-70.
14. Conn P.M. Handbook of Models for Human Aging 2006, Academic Press, Burlington, MA.
15. Dalle-Donne I., Rossi R., Colombo G., Giustarini D., Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem. Sci. 2009, 34:85-96.
16. De Marzo A.M., Marchi V.L., Epstein J.I., Nelson W.G. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am. J. Pathol. 1999, 155:1985-1992.
17. Donkena K.V., Young C.Y., Tindall D.J. Oxidative stress and DNA methylation in prostate cancer. Obstet. Gynecol. Int. 2010, 302051.
18. Ducros V., Faure P., Ferry M., Couzy F., Biajoux I., Favier A. The sizes of the exchangeable pools of selenium in elderly women and their relation to institutionalization. Br. J. Nutr. 1997, 78:379-396.
19. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat. Res. 2001, 475:123-139.
20. El-Bayoumy K., Richie J.P., Boyiri T., Komninou D., Prokopczyk B., Trushin N., Kleinman W., Cox J., Pittman B., Colosimo S. Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1459-1465.
21. El-Bayoumy K., Sinha R. Molecular chemoprevention by selenium: a genomic approach. Mutat. Res. 2005, 591:224-236.
22. Erden-Inal M., Sunal E., Kanbak G. Age-related changes in the glutathione redox system. Cell. Biochem. Funct. 2002, 20:61-66.
23. Facompre N., El-Bayoumy K. Potential stages for prostate cancer prevention with selenium: implications for cancer survivors. Cancer Res. 2009, 69:2699-2703.
24. Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999, 20:1657-1666.
25. Ghatak S., Ho S.M. Age-related changes in the activities of antioxidant enzymes and lipid peroxidation status in ventral and dorsolateral prostate lobes of noble rats. Biochem. Biophys. Res. Commun. 1996, 222:362-367.
26. Giustarini D., Rossi R., Milzani A., Colombo R., Dalle-Donne I. S-glutathionylation: from redox regulation of protein functions to human diseases. J. Cell. Mol. Med. 2004, 8:201-212.
27. Giustarini D., Dalle-Donne I., Colombo R., Petralia S., Giampaoletti S., Milzani A., Rossi R. Protein glutathionylation in erythrocytes. Clin. Chem. 2003, 49:327-330.
28. Hamid A.R., Umbas R., Mochtar C.A. Recent role of inflammation in prostate diseases: chemoprevention development opportunity. Acta Med. Indones. 2011, 43:59-65.
29. Hamilos D.L., Wedner H.J. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J. Immunol. 1985, 135:2740-2747.
30. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
31. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59:225-249.
32. Jesik C.J., Holland J.M., Lee C. An anatomic and histologic study of the rat prostate. Prostate 1982, 3:81-97.
33. Khandrika L., Kumar B., Koul S., Maroni P., Koul H.K. Oxidative stress in prostate cancer. Cancer Lett. 2009, 282:125-136.
34. Klatt P., Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur. J. Biochem. 2000, 267:4928-4944.
35. Klaunig J.E., Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 2004, 44:239-267.
36. Kleinman W.A., Komninou D., Leutzinger Y., Colosimo S., Cox J., Lang C.A., Richie J.P. Protein glutathiolation in human blood. Biochem. Pharmacol. 2003, 65:741-746.
37. Kleinman W.A., Richie J.P. Status of glutathione and other thiols and disulfides in human plasma. Biochem. Pharmacol. 2000, 60:19-29.
38. Lockett K.L., Snowhite I.V., Hu J.J. Nucleotide-excision repair and prostate cancer risk. Cancer Lett. 2005, 220:125-135.
39. Malins D.C., Johnson P.M., Wheeler T.M., Barker E.A., Polissar N.L., Vinson M.A. Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res. 2001, 61:6025-6028.
40. Masse J. Selenium status in aging. Am. J. Clin. Nutr. 1995, 61:1172-1173.
41. Mieyal J.J., Gallogly M.M., Qanungo S., Sabens E.A., Shelton M.D. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid. Redox Signal. 2008, 10:1941-1988.
42. Minelli A., Bellezza I., Conte C., Culig Z. Oxidative stress-related aging: a role for prostate cancer?. Biochim. Biophys. Acta 2009, 1795:83-91.
43. Morrissey C., Buser A., Scolaro J., O'Sullivan J., Moquin A., Tenniswood M. Changes in hormone sensitivity in the ventral prostate of aging Sprague-Dawley rats. J. Androl. 2002, 23:341-351.
44. Muller F.L., Lustgarten M.S., Jang Y., Richardson A., Van Remmen H. Trends in oxidative aging theories. Free Radic. Biol. Med. 2007, 43:477-503.
45. Muscat J.E., Kleinman W., Colosimo S., Muir A., Lazarus P., Park J., Richie J.P. Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radic. Biol. Med. 2004, 36:464-470.
46. Oberley T.D., Zhong W., Szweda L.I., Oberley L.W. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 2000, 44:144-155.
47. Olivieri O., Stanzial A.M., Girelli D., Trevisan M.T., Guarini P., Terzi M., Caffi S., Fontana F., Casaril M., Ferrari S., et al. Selenium status, fatty acids, vitamins A and E, and aging: the Nove Study. Am. J. Clin. Nutr. 1994, 60:510-517.
48. Platz E.A., Helzlsouer K.J. Selenium, zinc, and prostate cancer. Epidemiol. Rev. 2001, 23:93-101.
49. Pourmand G., Salem S., Moradi K., Nikoobakht M.R., Tajik P., Mehrsai A. Serum selenium level and prostate cancer: a case-control study. Nutr. Cancer 2008, 60:171-176.
50. Ray A.L., Semba R.D., Walston J., Ferrucci L., Cappola A.R., Ricks M.O., Xue Q.L., Fried L.P. Low serum selenium and total carotenoids predict mortality among older women living in the community: the women's health and aging studies. J. Nutr. 2006, 136:172-176.
51. Reyes I., Reyes N., Iatropoulos M., Mittelman A., Geliebter J. Aging-associated changes in gene expression in the ACI rat prostate: implications for carcinogenesis. Prostate 2005, 63:169-186.
52. Reznik G., Hamlin M.H., Ward J.M., Stinson S.F. Prostatic hyperplasia and neoplasia in aging F344 rats. Prostate 1981, 2:261-268.
53. Richie J.P. The role of glutathione in aging and cancer. Exp. Gerontol. 1992, 27:615-626.
54. Richie J.P., Kleinman W., Desai D.H., Das A., Amin S.G., Pinto J.T., El-Bayoumy K. The organoselenium compound 1,4-phenylenebis(methylene)selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorgenesis and enhances glutathione-related antioxidant levels in A/J mouse lung. Chem. Biol. Interact. 2006, 161:93-103.
55. Richie J.P., Komninou D., Leutzinger Y., Kleinman W., Orentreich N., Malloy V., Zimmerman J.A. Tissue glutathione and cysteine levels in methionine-restricted rats. Nutrition 2004, 20:800-805.
56. Richie J.P., Leutzinger Y., Parthasarathy S., Malloy V., Orentreich N., Zimmerman J.A. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J. 1994, 8:1302-1307.
57. Richie J.P., Muscat J.E., Ellison I., Calcagnotto A., Kleinman W., El-Bayoumy K. Association of selenium status and blood glutathione concentrations in blacks and whites. Nutr. Cancer 2011, 63:367-375.
58. Sabichi A.L., Lee J.J., Taylor R.J., Thompson I.M., Miles B.J., Tangen C.M., Minasian L.M., Pisters L.L., Caton J.R., Basler J.W., Lerner S.P., Menter D.G., Marshall J.R., Crawford E.D., Lippman S.M. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin. Cancer Res. 2006, 12:2178-2184.
59. Shirai T., Imaida K., Iwasaki S., Mori T., Tada M., Ito N. Sequential observation of rat prostate lesion development induced by 3,2'-dimethyl-4-aminobiphenyl and testosterone. Jpn. J. Cancer Res. 1993, 84:20-25.
60. Shirai T., Sano M., Tamano S., Takahashi S., Hirose M., Futakuchi M., Hasegawa R., Imaida K., Matsumoto K., Wakabayashi K., Sugimura T., Ito N. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res. 1997, 57:195-198.
61. Sies H. Glutathione and its role in cellular functions. Free Radic. Biol. Med. 1999, 27:916-921.
62. Simonoff M., Sergeant C., Garnier N., Moretto P., Llabador Y., Simonoff G., Conri C. Antioxidant status (selenium, vitamins A and E) and aging. EXS 1992, 62:368-397.
63. Sohal R.S., Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996, 273:59-63.
64. Tew K.D., Manevich Y., Grek C., Xiong Y., Uys J., Townsend D.M. The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic. Biol. Med. 2011, 51:299-313.
65. Thomas J.A., Mallis R.J. Aging and oxidation of reactive protein sulfhydryls. Exp. Gerontol. 2001, 36:1519-1526.
66. Townsend D.M., Tew K.D., Tapiero H. The importance of glutathione in human disease. Biomed. Pharmacother. 2003, 57:145-155.
67. Vogt T.M., Ziegler R.G., Graubard B.I., Swanson C.A., Greenberg R.S., Schoenberg J.B., Swanson G.M., Hayes R.B., Mayne S.T. Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int. J. Cancer 2003, 103:664-670.